➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Merck
Baxter
Johnson and Johnson
Harvard Business School

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Patent: 7,514,415

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,514,415
Title:Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
Abstract: The present disclosure relates to oligodeoxynucleotides that suppress an immune response. Methods are disclosed for preventing or treating inflammatory arthropathies by administering a therapeutically effective amount of a suppressive oligodeoxynucleotide.
Inventor(s): Klinman; Dennis (Potomac, MD), Zeuner; Rainald (Kiel, DE), Verthelyi; Daniela (Potomac, MD), Gursel; Ihsan (Rockville, MD), Gursel; Mayda (Rockville, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A)
Application Number:10/523,273
Patent Claims:see list of patent claims

Details for Patent 7,514,415

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A) 2022-08-01 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Start Trial The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A) 2022-08-01 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Start Trial The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A) 2022-08-01 RX Orphan search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Start Trial The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A) 2022-08-01 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Start Trial The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A) 2022-08-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKesson
Merck
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.